Liquidia Technologies, Inc. Aktie News

Liquidia Corporation ( LQDA ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM EST Company Participants Roger Jeffs - CEO & Director Michael Kaseta - COO & CFO Conference Call Participants Amy Li - Jefferies LLC, Research Division Presentation Amy Li Jefferies LLC, Research Division Hi, everyone, thanks so much for attending the Liquidia fireside chat. Day 2 of the conferen...

California-based TCG Crossover Management added 1.7 million shares of Liquidia for an estimated $38.9 million in the third quarter. The position represented 1.9% of reported assets at quarter-end.

Liquidia Corporation has just posted strong Q3 results after a recent FDA approval, and the commercial launch of YUTREPIA is showing solid early sales traction. The Q3 earnings beat has triggered numerous upward price target revisions for LQDA stock from analyst firms. Liquidia has a solid balance sheet and is well on its way to consistent profitability.

Liquidia Corporation ( LQDA ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Jason Adair - Chief Business Officer Roger Jeffs - CEO & Director Michael Kaseta - COO & CFO Scott Moomaw - Chief Commercial Officer Rajeev Saggar - Chief Medical Officer Russell Schundler - General Counsel & Corporate Secretary Conference Call Participants Amy Li - Jefferies LLC, Research Divi...

MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company's executive leadership team will be providing updates on the company's business during fireside chats at the following two investor conferences in No...

Liquidia Corporation ( LQDA ) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 PM EDT Company Participants Roger Jeffs - CEO & Director Rajeev Saggar - Chief Medical Officer Jason Adair - Chief Business Officer Conference Call Participants Richard Channick Rajan Saggar Ricardo Restrepo-Jaramillo Julian Harrison - BTIG, LLC, ...

MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its financial results an...

MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Development Day (R&D Day) on Tuesday, October 28, 2025, in New York City which will be webcast from 2:00 p.m. to 4:30 p.m. Eastern Standard Time.